Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2014 | Adult T-cell lymphoma/leukemia presenting as isolated central nervous system T-cell lymphoma | WEI-LI MA ; Li, Chi-Cheng; SHAN-CHI YU ; Tien, Hwei-Fang | Case reports in hematology | | 0 | |
2014 | Beta-Human Chorionic Gonadotropin Secreting Germinoma Refractory to Multi-Modality Treatment: A Case Report. | WEI-LI MA ; Feng-Ming Hsu; Sung-Hsin Kuo; Yu-Yun Shao | J. Cancer Res. Pract. | | 0 | |
2017 | Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas | WEI-LI MA ; MING YAO ; SHU-LANG LIAO ; JIH-LUH TANG ; Wang Y.-C.; SUNG-HSIN KUO ; ANN-LII CHENG | Oncotarget | 5 | 3 | |
2022 | Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens | WEI-LI MA ; Lin, Chia-Chi; FENG-MING HSU ; JANG-MING LEE ; JIN-SHING CHEN ; YEN-LIN HUANG ; YIH-LEONG CHANG ; Chang, Chin-Hao; CHIH-HSIN YANG | Cancer medicine | 2 | 2 | |
2022 | Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices | WEI-LI MA ; Chang, Dwan-Ying; CHING-HUNG LIN ; KAO-LANG LIU ; PO-CHIN LIANG ; HUANG-CHUN LIEN ; Hu, Chan-Chuan; Huang, Ling-Yun; Yeh, Yi-Chun; YEN-SHEN LU | The oncologist | 0 | 0 | |
2016 | Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection | WEI-LI MA ; HSIN-AN HOU ; Hsu Y.-J.; YIN-KAI CHEN ; JIH-LUH TANG ; Yeh P.-T.; PO-TING YEH ; CHUNG-MAY YANG ; Tien H.-F.; HWEI-FANG TIEN | Annals of Hematology | 38 | 34 | |
2019 | Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study | WEI-LI MA ; CHIA-CHI LIN ; FENG-MING HSU ; JANG-MING LEE ; JIN-SHING CHEN ; MIN-SHU HSIEH ; YIH-LEONG CHANG ; Chao Y.-T.; Chang C.-H.; CHIH-HSIN YANG | Clinical Lung Cancer | 9 | 9 | |
2021 | Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas | WEI-LI MA ; KUN-HUEI YEH ; MING YAO ; JIH-LUH TANG ; CHUNG-WU LIN ; Wang Y.-T.; Yeh Y.-C.; HSIU-PO WANG ; ANN-LII CHENG ; SUNG-HSIN KUO | Journal of the Formosan Medical Association | 3 | 3 | |
2020 | Efficacy of a programmed death-1 checkpoint inhibitor in a case of cutaneous squamous cell carcinoma harboring mutations of TP53 and BRCA2 | WEI-LI MA ; Chou C.-H.; JO-PAI CHEN ; SUNG-HSIN KUO | Dermatologic Therapy | 1 | 1 | |
2022 | First-line antibiotic treatment in patients with localized extragastric mucosa-associated lymphoid tissue lymphoma | Ming Yao; Shu-Lang Liao; Chung-Wu Lin; Cheng-Ping Wang; WEI-LI MA ; Yi-Hsuan Wei; Jyh-Ming Liou; I-Jong Wang; ANN-LII CHENG ; SUNG-HSIN KUO | eJHaem | | 0 | |
2023 | Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma | Cheng, Chieh-Lung; Yeh, Po-Ting; Fang, Wei-Quan; WEI-LI MA ; HSIN-AN HOU ; Tsai, Cheng-Hong; Lin, Chang-Ping; Tien, Hwei-Fang | Cancer medicine | 0 | 0 | |
2014 | Primary Pleural Epithelioid Angiosarcoma Presenting with Persistent Pleural Effusion and Bone Metastases | WEI-LI MA ; Jo-Pai Chen | J. Cancer Res. Pract. | | 0 | |
2021 | Role of alpelisib in the treatment of pik3ca-mutated breast cancer: Patient selection and clinical perspectives | DWANG-YING CHANG ; WEI-LI MA ; YEN-SHEN LU | Therapeutics and Clinical Risk Management | 17 | 16 | |